ConductScience.org, home

Paper36689727

Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.

Heidenreich F and 25 others. Blood Adv, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. Papers, record 36689727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36689727

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.
PubMed
Journal
Blood Adv
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2023-07-07
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heidenreich FFalkhttps://orcid.org/0000-0001-8525-2810
2Falk BBose
3Baldauf HHenning
4Massalski CCarolin
5Schäfer GGesine
6Rücker-Braun EElkehttps://orcid.org/0000-0002-0943-031X
7Altmann HHeidi
8Sauter JJürgenhttps://orcid.org/0000-0001-8485-2945
9Solloch UVUte Vhttps://orcid.org/0000-0002-5910-7510
10Lange VVinzenzhttps://orcid.org/0000-0002-6442-9573
11Stölzel FFriedrichhttps://orcid.org/0000-0003-0653-5332
12Röllig CChristoph
13Middeke JMJan M
14von Bonin MMalte
15Thiede CChristianhttps://orcid.org/0000-0003-1241-2048
16Schäfer-Eckart KKerstin
17Müller-Tidow CCarstenhttps://orcid.org/0000-0002-7166-5232
18Krause SWStefan Whttps://orcid.org/0000-0002-5259-4651
19Kraus SSabrina
20Kaufmann MMartin

Source PubMed

See all 26 authorsDownload CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, KIRMajor topic
Leukemia, Myeloid, AcuteMajor topic
Humans
Case-Control Studies
Ligands
Genotype

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126983546The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.J Hematol Oncol2016https://conductscience.org/library/papers/26983546PubMed
231681270Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells.Front Immunol2019https://conductscience.org/library/papers/31681270PubMed
318841361Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.Cancer Immunol Immunother2009https://conductscience.org/library/papers/18841361PubMed
430564239Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations.Front Immunol2018https://conductscience.org/library/papers/30564239PubMed
532092137KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.Blood Adv2020https://conductscience.org/library/papers/32092137PubMed
612391228Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.J Immunol2002https://conductscience.org/library/papers/12391228PubMed
732102404Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer.Cells2020https://conductscience.org/library/papers/32102404PubMed
826744525Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.Cancer Res2016https://conductscience.org/library/papers/26744525PubMed
919903900Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.Blood2010https://conductscience.org/library/papers/19903900PubMed
1024018270HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.J Immunol2013https://conductscience.org/library/papers/24018270PubMed
1131644966Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.Leuk Res2019https://conductscience.org/library/papers/31644966PubMed
1233257819Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients.Genes Immun2020https://conductscience.org/library/papers/33257819PubMed
1329358179Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.Blood2018https://conductscience.org/library/papers/29358179PubMed
1427446203The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Front Genet2016https://conductscience.org/library/papers/27446203PubMed
1532767509Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia.Int J Immunogenet2020https://conductscience.org/library/papers/32767509PubMed
1622768326Activating KIR and HLA Bw4 ligands are associated to decreased susceptibility to pemphigus foliaceus, an autoimmune blistering skin disease.PLoS One2012https://conductscience.org/library/papers/22768326PubMed
1720600442Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.Hum Immunol2010https://conductscience.org/library/papers/20600442PubMed
1831379844Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.Front Immunol2019https://conductscience.org/library/papers/31379844PubMed
1919493232Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.Tissue Antigens2009https://conductscience.org/library/papers/19493232PubMed
2025740999Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.J Virol2015https://conductscience.org/library/papers/25740999PubMed

See all 46 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42712389Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation.Front Immunol2026https://conductscience.org/library/papers/42712389PubMed
40244151The Role of Killer Ig-like Receptors in Diseases from A to Z.Int J Mol Sci2025https://conductscience.org/library/papers/40244151PubMed

Download CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
HLA-DRB13123PubTator's text mininghttps://conductscience.org/library/genes/3123NCBI Gene
HLA-F3134PubTator's text mininghttps://conductscience.org/library/genes/3134NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
KIR2DL13802PubTator's text mininghttps://conductscience.org/library/genes/3802NCBI Gene
KIR2DL23803PubTator's text mininghttps://conductscience.org/library/genes/3803NCBI Gene
KIR2DL33804PubTator's text mininghttps://conductscience.org/library/genes/3804NCBI Gene
KIR2DL43805PubTator's text mininghttps://conductscience.org/library/genes/3805NCBI Gene
KIR2DL5A57292PubTator's text mininghttps://conductscience.org/library/genes/57292NCBI Gene
KIR2DP1554300PubTator's text mininghttps://conductscience.org/library/genes/554300NCBI Gene
KIR2DS13806PubTator's text mininghttps://conductscience.org/library/genes/3806NCBI Gene
KIR2DS43809PubTator's text mininghttps://conductscience.org/library/genes/3809NCBI Gene
KIR3DL13811PubTator's text mininghttps://conductscience.org/library/genes/3811NCBI Gene
KIR3DL23812PubTator's text mininghttps://conductscience.org/library/genes/3812NCBI Gene
KIR3DL3115653PubTator's text mininghttps://conductscience.org/library/genes/115653NCBI Gene
KIR3DS13813PubTator's text mininghttps://conductscience.org/library/genes/3813NCBI Gene
KLRC23822PubTator's text mininghttps://conductscience.org/library/genes/3822NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36689727

GET https://conductscience.org/api/papers/v1/36689727/authors?page=2